EV/EBITDA:
-14.86+0.22(+1.46%)Summary
- As of today (July 13, 2025), CGON EV/EBITDA is -14.86, with a rise of +0.22 (+1.46%) during the most recent trading session on July 11, 2025.
- Over the past year, CGON EV/EBITDA has increased by +12.95 (+46.57%).
- CGON EV/EBITDA is now -74.00% below its all-time high of -8.54.
Performance
CGON EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CGON EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.5% | -1.5% | -1.4% |
| 1 m1 month | -2.1% | +2.1% | +2.1% |
| 3 m3 months | -39.7% | +39.7% | +38.6% |
| 6 m6 months | +16.6% | -2.3% | -11.5% |
| ytdytd | +11.6% | +3.6% | -6.8% |
| 1 y1 year | +46.6% | -12.2% | -22.5% |
| 5 y5 years | - | - | - |
CGON EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -14.14 | -5.1% | -15.08 | +1.5% |
| 3 m | 3-month | -10.64 | -39.7% | -16.18 | +8.2% |
| 6 m | 6-month | -8.54 | -74.0% | -18.21 | +18.4% |
| 1 y | 1-year | -8.54 | -74.0% | -31.81 | +53.3% |
| 3 y | 3-year | -8.54 | -74.0% | -57.35 | +74.1% |
| 5 y | 5-year | -8.54 | -74.0% | -57.35 | +74.1% |
| alltime | all time | -8.54 | -74.0% | -57.35 | +74.1% |
CGON EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.86(-11.6%) |
| Date | Value |
|---|---|
| 2024 | -16.81 |
FAQ
- What is CG Oncology, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for CG Oncology, Inc.?
- What is CGON EV/EBITDA year-to-date change?
- What is CG Oncology, Inc. EV/EBITDA year-on-year change?
What is CG Oncology, Inc. EV/EBITDA?
The current EV/EBITDA of CGON is -14.86
What is the all time high EV/EBITDA for CG Oncology, Inc.?
CG Oncology, Inc. all-time high EV/EBITDA is -8.54
What is CGON EV/EBITDA year-to-date change?
CG Oncology, Inc. EV/EBITDA has changed by +1.95 (+11.60%) since the beginning of the year
What is CG Oncology, Inc. EV/EBITDA year-on-year change?
Over the past year, CGON EV/EBITDA has changed by +12.95 (+46.57%)